Sulfide, sulfoxide and sulfone bridged acyclic nucleoside phosphonates as inhibitors of the Plasmodium falciparum and human 6-oxopurine phosphoribosyltransferases: Synthesis and evaluation
Language English Country France Media print-electronic
Document type Journal Article
PubMed
31536893
DOI
10.1016/j.ejmech.2019.111667
PII: S0223-5234(19)30811-6
Knihovny.cz E-resources
- Keywords
- Acyclic nucleoside phosphonates, Hypoxanthine-guanine-xanthine phosphoribosyltransferase, Plasmodium falciparum, Sulfide oxidation, Sulfur-containing drugs,
- MeSH
- Antimalarials chemical synthesis pharmacology MeSH
- Humans MeSH
- Molecular Structure MeSH
- Nucleosides chemical synthesis pharmacology MeSH
- Organophosphonates chemical synthesis pharmacology MeSH
- Oxidation-Reduction MeSH
- Pentosyltransferases antagonists & inhibitors MeSH
- Plasmodium falciparum drug effects enzymology MeSH
- Prodrugs chemical synthesis pharmacology MeSH
- Sulfides chemistry MeSH
- Sulfones chemistry MeSH
- Sulfoxides chemistry MeSH
- Thermodynamics MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Antimalarials MeSH
- hypoxanthine-guanine-xanthine phosphoribosyltransferase MeSH Browser
- Nucleosides MeSH
- Organophosphonates MeSH
- Pentosyltransferases MeSH
- Prodrugs MeSH
- Sulfides MeSH
- Sulfones MeSH
- Sulfoxides MeSH
Hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT) is a recognized target for antimalarial chemotherapeutics. It synthesises all of the 6-oxopurine nucleoside monophosphates, IMP, GMP and XMP needed by the malarial parasite, Plasmodium falciparum (Pf). PfHGXPRT is also indirectly responsible for the synthesis of the adenosine monophosphate, AMP. The acyclic nucleoside phosphonates (ANPs) are a class of PfHGXPRT inhibitors. Prodrugs of these compounds are able to arrest the growth of Pf in cell culture. In the search for new inhibitors of PfHGXPRT, a series of sulfur containing ANPs (thia-ANPs) has been designed and synthesized. These compounds are based on the structure of 2-(phosphonoethoxy)ethylguanine (PEEG) and PEEHx which consist of a purine base (i.e. guanine or hypoxanthine) linked to a phosphonate group by five atoms i.e. four carbons and one oxygen. Here, PEEG and PEEHx were modified by substituting a sulfide, sulfoxide or a sulfone bridge for the oxygen atom in the linker. The effect of these substitutions on the Ki values for human HGPRT and PfHGXPRT was investigated and showed that most of the thia-ANPs distinctively favour PfHGXPRT. For example, the thia-analogue of PEEHx has a Ki value of 0.2 μM for PfHGXPRT, a value 25-fold lower than for the human counterpart. Prodrugs of these compounds have IC50 values in the 4-6 μM range in antimalarial cell-based assays, making them attractive compounds for further development as antimalarial drug leads.
References provided by Crossref.org
Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects